Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: This study aims to evaluate the efficacy of various conventional synthetic DMARDs, including Hook F (TwHF) for treating rheumatoid arthritis (RA) by network meta-analysis.
Methods: We retrieved the related literature from online databases and supplemented it by using a manual retrieval method. Data was extracted from the literature and analyzed with STATA software.
Results: A total of 21 trials (5,039 participants) were identified. Assessment of ACR20 response found that TwHF combined with methotrexate (MTX) had the greatest probability for being the best treatment option among the treatments involved, while TwHF used singly was second only to TwHF combined with MTX. Assessment of ACR50 response found that TwHF combined with MTX ranked second in all treatment options after cyclosporine A (CsA) combined with leflunomide (LEF) and TwHF alone, followed by TwHF combined with MTX. Assessment of ACR70 response found that CsA combined with LEF ranked first, TwHF combined with LEF ranked second, TwHF combined with MTX ranked third, and TwHF used singly ranked fourth. In the safety analysis, TwHF had the least probability of adverse event occurrence, followed by TwHF combined with MTX, which ranked first and second, respectively.
Conclusion: Compared with the current csDMARDs for treating RA, the efficacy of TwHF was clear, and TwHF combined with MTX performed well under various endpoints. In the future, large, rigorous, and high-quality RCTs are still needed to confirm the benefits of TwHF therapy on RA.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113883 | PMC |
| http://dx.doi.org/10.1155/2022/3181427 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Triptolide Inhibits Epileptic Seizures by Rescuing the Neuroinflammation-Related GABAergic Dysfunction in Mice.
CNS Neurosci Ther
August 2025
Research Institute of Chinese Medical Clinical Foundation and Immunology & TCM Science and Research Center, Wenzhou TCM Hospital of Zhejiang Chinese Medical University, College of Basic Medical Science, Zhejiang Chinese Medical University, Zhejiang, China.
Objective: This study aims to evaluate the antiepileptic effect of triptolide (TPL), a strong anti-inflammatory and immunosuppressive diterpenoid compound from a Chinese herb medicine Tripterygium wilfordii Hook F (TWHF).
Methods: The pentylenetetrazol (PTZ)-induced seizure model, maximal electroshock seizure (MES) model, corneal (6 Hz) kindling model, and kainic acid (KA) mouse model were used to assess the antiepileptic effect of TPL. EEG recording and behavioral tests were used to evaluate the disease-modifying effects of TPL in epileptic conditions.
Towards high mobility and adaptive mode transitions: Transformable wheel-biped humanoid locomotion strategy.
ISA Trans
March 2025
School of Mechatronical Engineering, Beijing Institute of Technology, Beijing, 100081, China; Key Laboratory of Biomimetic Robots and Systems, Ministry of Education, Beijing, 100081, China; National Key Lab of Autonomous Intelligent Unmanned Systems, Beijing, 100081, China. Electronic address: qhuan
Wheel-biped humanoid robots offer a promising solution that combines the bipedal locomotion and manipulation capabilities of humanoids with the mobility advantages of wheeled robots. However, achieving high mobility and adaptive wheel-foot transitions while maintaining essential bipedal functionality in a transformable wheel-biped configuration (TWBC) presents a significant challenge. To address this, this paper proposes a transformable wheel-humanoid framework (TWHF), which enhances traditional humanoid robots by incorporating a compact, decoupled wheeled subsystem.
View Article and Find Full Text PDFArticle Synopsis
- This study aimed to compare the effectiveness and safety of adalimumab (ADA) with a herbal remedy called Tripterygium wilfordii (TwHF) against ADA combined with methotrexate (MTX) for patients with rheumatoid arthritis (RA) who did not respond well to MTX.
- Conducted with 64 RA patients, the trial included a treatment group (ADA + TwHF) and a control group (ADA + MTX), monitoring outcomes over 24 weeks for low disease activity and remission rates.
- Results showed no significant differences in efficacy or safety between the two treatment options, indicating that TwHF could be a viable alternative for RA patients who cannot
Bibliometric analysis of trends in research of Tripterygium wilfordii Hook F for treating rheumatoid arthritis.
Medicine (Baltimore)
November 2023
Department of Traditional Chinese Medicine External Treatment Center, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
Tripterygium wilfordii Hook F (TwHF) has been widely used to relieve rheumatoid arthritis (RA) in many countries. However, a bibliometric analysis of published articles discussing this treatment has not been conducted. This study aimed to explore the current status and trends of TwHF for treating RA.
View Article and Find Full Text PDF2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis.
J Autoimmun
January 2024
AMPEL BioSolutions LLC and the RILITE Research Institute, Charlottesville, VA, USA. Electronic address:
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disorder that affects the joints and produces pain, swelling, and stiffness. It has a lifetime prevalence of up to 1% worldwide. An extract of Tripterygium wilfordii Hook F (TwHF), a member of the Celastraceae herbal family widely available in south China, has been used for treatment of RA since 1960s.
View Article and Find Full Text PDF